Due to the extensive use of this medication, many people may have potential claims.
After recent studies found Zantac, a medication frequently used for relief from or prevention of heartburn, acid reflux, and stomach and intestinal ulcers, contained a known carcinogen, called NDMA, in an amount far exceeding the limit set by the FDA, many people are claiming injuries related to their use of the drug. The medication, which could be purchased over the counter or by prescription, has been the subject of a voluntary recall. Zantac was used to reduce the amount of acid in the stomach and was a common choice by doctors for patients suffering from stomach or esophageal discomfort.
The ranitidine molecule, the key ingredient of Zantac, has been proven to break down into NDMA, a potent carcinogen. Tests have shown this breakdown can occur when ranitidine is exposed to elevated temperatures such as being in a hot car during transport or in the contents of the stomach. N-Nitrosodimethylamine (NDMA) has been shown to increase the risk of cancer among humans exposed to high levels over a short-term, or low levels over a long period of time. Scientists have been aware of the toxic effects of this chemical for over 40 years. NDMA has been linked to an increased risk of certain types of cancers including….
- Kidney Cancer
- Bladder Cancer
- Colorectal Cancer
- Intestinal Cancer
- Liver Cancer
- Pancreatic Cancer
- Stomach Cancer
While the pharmaceutical company knew or should have known about the link between Zantac and cancer due the presence of NDMA, they failed to adequately research the possible side effects or warn patients and prescribers of possible issues. Due to the extensive use of this medication, many people may have potential claims.
If you or a loved one took Zantac for a year or more and have developed one of the cancers listed above, you may be eligible to participate in this lawsuit. Let us help you get the compensation you deserve. Contact Cordisco & Saile, LLC for a free consultation.
